Products for Research Use Only
RegisterLogin

Ormutivimab

CAT: 0804-HY-P99792Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99792Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model[1][2].
CAS Number
2449086-91-1
Product Name Alternative
NM57; rhRIG
UNSPSC
12352203
Target
RABV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ormutivimab.html
Solubility
10 mM in DMSO
Smiles
[Ormutivimab]
References & Citations
[1]Zhai LL, et al. Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models. Travel Med Infect Dis. 2022 Mar-Apr;46:102267. |[2]Zhang J, et al. Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects. Vaccines (Basel) . 2022 Jul 29;10 (8) :1218.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T80594-01Ormutivimab
GTR18334168-01Ormutivimab Antibody
WA3306Research Grade Ormutivimab
E55B0856Ormutivimab (Reference antibody)
ICH5745-10mgOrmutivimab Biosimilar - Research Grade
GTR18697277-01Ormutivimab Human Monoclonal Antibody
GTR18780240-01(Ormutivimab) Biosimilar Reference Antibody
A135564Ormutivimab Biosimilar (Monoclonal, IgG1, lambda2)
PX-TA1796-01Ormutivimab Biosimilar - Anti-G Glycoprotein mAb - Research Grade
RA0627-01Ormutivimab (Biosimilar Reference Antibody) (Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1)

Popular Products